MARATTO

article · Archives of Phytopathology and Plant Protection

Fungicide screening for the management of faba bean gall (<i>Physoderma vacia</i>) disease in Ethiopia

Abstract

Physoderma vacia is recently identified fungi which causes faba bean gall (FBG) in Ethiopia. Although the disease is new to the country, its epidemiology and management is not well known yet. Thus, this study was initiated to select a readily available fungicide/s with high efficacy level against FBG. Field experiment was conducted for two following years at Mush and Degem using RCB-Design with three replications. ANOVA showed significant differences (P ≤ 0.05) between fungicides in disease and yield parameters. Maximum percent severity index (PSI) (47.4 and 81.27%) and area under disease progress curve (AUDPC) (1401.178 and 2367.91%)-days were observed from control, while minimum PSI (13.6 and 37.21%) and AUDPC (387.33 and 1077.17%)-days were noticed from Nativo SC 300 fungicide on both 2019 and 2020 growing seasons, respectively. Moreover, Nativo SC 300 recorded maximum grain yield (kg/ha) 3415.85 in 2019 and 2488.17 in 2020 production year. Conversely, control resulted minimum grain yield (2040.1 and 1130.1 kg/ha) in 2019 and 2020 growing seasons, respectively. However, Amistar xtra 280 SC, Rexdo and Payrazol were phyto-toxic to faba bean per factory recommendations. Spraying Nativo SC 300 fungicide to manage FBG would provide 120.13% grain yield advantage over control.

Research topics

  • Genetic and Environmental Crop Studies
  • Agricultural pest management studies
  • Plant-Microbe Interactions and Immunity

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1080/03235408.2022.2123584

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.